Item 16. FORM 10-K SUMMARY

5K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.


			HUMANA INC.

			By:						/s/ SUSAN M. DIAMOND
									Susan M. Diamond
									Chief Financial Officer (Principal Financial Officer)

			Date:						February 16, 2023

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the date indicated.


Signature	Title	Date

/s/ SUSAN M. DIAMOND	Chief Financial Officer (Principal Financial Officer)	February 16, 2023
Susan M. Diamond

/s/ JOHN-PAUL W. FELTER	Senior Vice President, Chief Accounting Officer and Controller (Principal Accounting Officer)	February 16, 2023
John-Paul W. Felter

/s/ BRUCE D. BROUSSARD	President and Chief Executive Officer, Director (Principal Executive Officer)	February 16, 2023
Bruce D. Broussard

/s/ KURT J. HILZINGER	Chairman of the Board	February 16, 2023
Kurt J. Hilzinger

/s/ RAQUEL C. BONO, M.D.	Director	February 16, 2023
Raquel C. Bono, M.D.

/s/ FRANK A. D’AMELIO	Director	February 16, 2023
Frank A. D’Amelio

/s/ DAVID T. FEINBERG, M.D.	Director	February 16, 2023
David T. Feinberg, M.D.

/s/ WAYNE A. I. FREDERICK, M.D.	Director	February 16, 2023
Wayne A. I. Frederick, M.D.

/s/ JOHN W. GARRATT	Director	February 16, 2023
John W. Garratt

/s/ DAVID A. JONES, JR.	Director	February 16, 2023
David A. Jones, Jr.

/s/ KAREN W. KATZ	Director	February 16, 2023
Karen W. Katz

/s/ MARCY S. KLEVORN	Director	February 16, 2023
Marcy S. Klevorn

/s/ WILLIAM J. MCDONALD	Director	February 16, 2023
William J. McDonald

/s/ JORGE S. MESQUITA	Director	February 16, 2023
Jorge S. Mesquita

/s/ JAMES J. O’BRIEN	Director	February 16, 2023
James J. O’Brien

/s/ BRAD D. SMITH	Director	February 16, 2023
Brad D. Smith

Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULE